Ampersand Capital backs GenDx

Ampersand Capital Partners has made a minority investment in GenDx, a Dutch provider of molecular diagnostic kits and analysis software for transplantation and companion diagnostics. No financial terms were disclosed.

8 May 2019•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles